The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Crisis in Antibiotic Resistance
Abstract
The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overuse and antibiotic resistance have proliferated[422]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [422]
Citations
Cites
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593
Research works printed but not linked: 30
- AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
- APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
- BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
- BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
- Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
- BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
- BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
- COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
- DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
- Fisher, M., New Antibacterial Strategies 177 (1990).
- Higgins, C. F., New Antibacterial Strategies 193 (1990).
- KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
- LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
- McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
- MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
- Mitsuhashi, S., The Aminoglycosides 97 (1982).
- MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
- MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
- NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
- NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
- Neu, H. C., Human Pharmacology 613 (1991).
- Normark, S., New Antibacterial Strategies 161 (1990).
- PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
- SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
- SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
- SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
- SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
- TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
- TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
- UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).
Cited by
Sorted by citations
Items 301–400 of 1,000
Synthetic macromolecules as therapeutics that overcome resistance in cancer and microbial infection
Tan, J., Tay, J., Hedrick, J. L., & Yang, Y. Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120078 · Cited by 143
Fayaz, A. M., Girilal, M., Mahdy, S. A., Somsundar, S. S., Venkatesan, R., & Kalaichelvan, P. T. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.11.001 · Cited by 142
The glycopeptide story – how to kill the deadly ‘superbugs’
Williams, D. H. (1996) · Natural Product Reports · doi:10.1039/np9961300469 · Cited by 141
Cira, N., Ho, J. Y., Dueck, M. E., & Weibel, D. B. (2011) · Lab on a Chip · doi:10.1039/c2lc20887c · Cited by 141
Sedghi, R., Shaabani, A., Mohammadi, Z., Samadi, F., & Isaei, E. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.12.011 · Cited by 141
Antimicrobial Resistance: Implications for the Food System
(2006) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2006.00004.x · Cited by 140
Reasons for the Emergence of Antibiotic Resistance
Tenover, F. C., & McGowan, J. E. (1996) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)41625-8 · Cited by 141
Probiotics: An emerging food supplement with health benefits
Agrawal, R. (2005) · Food Biotechnology · doi:10.1080/08905430500316474 · Cited by 140
“The rate of increase in resistance to antibiotics is a major public health problem all over the world (Neu, 1994; Bengmark, 1998).”
Taylor, E. N., Kummer, K. M., Durmus, N. G., Leuba, K., Tarquinio, K. M., & Webster, T. J. (2012) · Small · doi:10.1002/smll.201200575 · Cited by 140
Synthesis of Chitosan-Based Gold Nanoparticles: Antimicrobial and Wound-Healing Activities
Hashem, A. H., Shehabeldine, A. M., Ali, O. M., & Salem, S. S. (2022) · Polymers · doi:10.3390/polym14112293 · Cited by 141
“The emergence of multidrug-resistant (MDR) bacteria has become a severe threat to public health [1].”
BackgroundWright, G. D., Holman, T. R., & Walsh, C. T. (1993) · Biochemistry · doi:10.1021/bi00070a013 · Cited by 137
Schentag, J. J., Hyatt, J. M., Carr, J. R., Paladino, J. A., Birmingham, M. C., Zimmer, G. S., & Cumbo, T. J. (1998) · Clinical Infectious Diseases · doi:10.1086/520287 · Cited by 140
“cally altered the focus of clinical medicine, at least for the next several decades [1, 2].”
BackgroundClubbed triazoles: A novel approach to antitubercular drugs
Shiradkar, M. R., Kumar, G. V. S., Dasari, V., Tatikonda, S., Akula, K. C., & Shah, R. M. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.001 · Cited by 139
Wybenga-Groot, L. E., Draker, K.-A., Wright, G. D., & Berghuis, A. M. (1999) · Structure · doi:10.1016/s0969-2126(99)80066-5 · Cited by 139
Histidine kinases as targets for new antimicrobial agents
Matsushita, M., & Janda, K. D. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00355-8 · Cited by 136
ALIO, J. L., Abbouda, A., Díaz‐Valle, D., del Castillo, J. M., & Fernandez, J. A. (2013) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/1869-5760-3-47 · Cited by 135
“Microbes develop resistance to antibiotics as a result of chromosomal mutation, inductive expression of latent chromosomal genes, or exchange of genetic material via transformation, bacteriophage transduction, or plasmid conjugation [10-12].”
BackgroundGonzález-Pleiter, M., Pedrouzo-Rodríguez, A., Verdú, I., Leganés, F., Marco, E., Rosal, R., & Fernández‐Piñas, F. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.128824 · Cited by 137
“, 2015) and, most importantly, they may trigger the increase and spread of antibiotic resistance bacteria and cognate antibiotic resistance genes (Neu, 1992).”
BackgroundThe sex pheromone system of Enterococcus faecalis
Wirth, R. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18862.x · Cited by 134
Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli
Maneewannakul, K., & Levy, S. B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1695 · Cited by 135
Liang, J., Melican, D. T., Cafro, L., Palace, G. P., Fisette, L., Armstrong, R., & Patchen, M. L. (1998) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(98)00007-1 · Cited by 135
Strynadka, N. C. J., Jensen, S. E., Alzari, P. M., & James, M. N. G. (1996) · Nature Structural Biology · doi:10.1038/nsb0396-290 · Cited by 134
Siderophores of Fluorescent Pseudomonads
Budzikiewicz, H. (1997) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1997-11-1201 · Cited by 134
Enzyme‐Coated Mesoporous Silica Nanoparticles as Efficient Antibacterial Agents In Vivo
Li, L., & Wang, H. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300051 · Cited by 133
Anti-Biofilm Compounds Derived from Marine Sponges
Stowe, S. D., Richards, J. J., Tucker, A. T., Thompson, R. J., Melander, C., & Cavanagh, J. (2011) · Marine Drugs · doi:10.3390/md9102010 · Cited by 135
“This level of protection is also extended to protect invading bacteria against the host’s immune defenses and has been shown to increase bacterial resistance to conventional antibiotics by nearly 1000-fold [53–55].”
BackgroundLayer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications
Wu, Y., Long, Y., Li, Q., Han, S., Ma, J., Yang, Y., & Gao, H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b04216 · Cited by 134
Rational Design of Berberine-Based FtsZ Inhibitors with Broad-Spectrum Antibacterial Activity
Sun, N., Chan, F., Lu, Y., Neves, M. A. C., Lui, H., Wang, Y., Chow, K.-Y., Chan, K., Yan, S., Leung, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097514 · Cited by 132
Ciloglu, F. U., Sarıdağ, A. M., Kılıç, İ. H., Tokmakçı, M., Kahraman, M., & Aydin, Ö. F. (2020) · The Analyst · doi:10.1039/d0an00476f · Cited by 132
Austin, D. J., Kakehashi, M., & Anderson, R. M. (1997) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1997.0227 · Cited by 132
“The continuing spread of antibiotic resistance in a wide variety of important bacterial pathogens is a cause of concern in many regions of the world (Cohen 1992; Neu 1992; Greenwood 1995).”
BackgroundThe synthesis and SAR of rhodanines as novel class C β-lactamase inhibitors
Grant, E. B., Guiadeen, D., Baum, E. Z., Foleno, B. D., Jin, H., Montenegro, D. A., Nelson, E. A., Bush, K., & Hlasta, D. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00444-3 · Cited by 132
Kawashima, N., Wadachi, R., Suda, H., Yeng, T., & Parashos, P. (2009) · International Dental Journal · doi:10.1016/s0020-6539(20)33797-7 · Cited by 131
Smith, T. L., & Jarvis, W. R. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80082-3 · Cited by 138
The challenge of antibiotic resistance: need to contemplate.
Kapil, A. (2005) · PubMed · Cited by 131
Natural Products in Drug Discovery: Present Status and Perspectives
Molinari, G. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1132-2_2 · Cited by 136
Emerging Waterborne Infections: Contributing Factors, Agents, and Detection Tools
Theron, J., & Cloete, T. E. (2002) · Critical Reviews in Microbiology · doi:10.1080/1040-840291046669 · Cited by 130
Ali, M. (2009) · American Journal of Environmental Sciences · doi:10.3844/ajes.2009.47.52 · Cited by 129
“Moreover, antibiotic treatment is considered the most important issue that promotes the emergence, selection and spreading of antibioticresistant microorganisms in both veterinary and human medicine (Neu 1992; Witte 1998).”
BackgroundHalawani, E. M., & Arabia, S. (2009) · Cited by 129
Jia, A., Hu, J., Wu, X., Peng, H., Wu, S., & Dong, Z. (2011) · Environmental Toxicology and Chemistry · doi:10.1002/etc.508 · Cited by 131
“sulfadimethoxine could induce carcinomas [5–7].”
Therapy-Induced Alterations in Host Defense in Children Receiving Therapy for Cancer
Lehrnbecher, T., Foster, C. B., Vázquez, N., Mackall, C. L., & Chanock, S. J. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00001 · Cited by 129
Wong, S. H., Bryant, P., Ward, M. C. L., & Wharton, C. W. (2003) · Sensors and Actuators B Chemical · doi:10.1016/s0925-4005(03)00447-7 · Cited by 128
Hatakka, K., Blomgren, K., Pohjavuori, S., Kaijalainen, T., Poussa, T. A., Leinonen, M., Korpela, R., & Pitkäranta, A. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.01.003 · Cited by 127
Kim, C., Ryu, H.-D., Chung, E. G., Kim, Y.-S., & Lee, J. (2018) · Journal of Environmental Management · doi:10.1016/j.jenvman.2018.04.006 · Cited by 127
Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
Peterson, L. R. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01238.x · Cited by 128
“More than 10 years ago, Dr Harold Neu sounded the alarm over increasing antibiotic resistance [5] .”
BackgroundMaveyraud, L., Golemi, D., Kotra, L. P., Tranier, S., Vakulenko, S. B., Mobashery, S., & Samama, J. (2000) · Structure · doi:10.1016/s0969-2126(00)00534-7 · Cited by 127
Rapid changes in clonal lines: the death of a ‘sacred cow’
Loxdale, H. D., & Lushai, G. (2003) · Biological Journal of the Linnean Society · doi:10.1046/j.1095-8312.2003.00177.x · Cited by 127
“Away from the experimental bench, bacteria have evolved rapidly in recent years under intense antibiotic selective pressure to develop resistance, rather as aphids have done in response to intense pesticide selective pressure, both in the laboratory and field (Neu, 1992; Foster et al., 1998, 2000).”
BackgroundMarine Microorganisms and Drug Discovery: Current Status and Future Potential
Jensen, P. R., & Fenical, W. (2000) · KARGER eBooks · doi:10.1159/000062490 · Cited by 127
Tran, T., Nguyen, T.-T.-N., Do, T.-H., Huynh, T.-N.-P., Tran, C.-D., & Thai, K. (2012) · Molecules · doi:10.3390/molecules17066684 · Cited by 126
“With the emergence of new microbial strains resistant to many conventional available antibiotics there is growing interest in the discovery of new antibacterial agents [1,2].”
BackgroundBovine colostrum: an emerging nutraceutical
Parab, S. B., Tharappel, L. J. P., Kaur, G., & Buttar, H. S. (2015) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2014-0039 · Cited by 126
Targets for Combating the Evolution of Acquired Antibiotic Resistance
Culyba, M. J., Mo, C. Y., & Kohli, R. M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00109 · Cited by 135
Schlüsener, M. P., Spiteller, M., & Bester, K. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00737-4 · Cited by 125
Subbalakshmi, C., Krishnakumari, V., Nagaraj, R., & Sitaram, N. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00996-9 · Cited by 125
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Hansen, E., Woods, R. J., & Read, A. F. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001110 · Cited by 123
Treatment of Bacterial Urinary Tract Infections: Presence and Future
Wagenlehner, F. R. A., & Naber, K. G. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.017 · Cited by 124
“1 – Target and mechanism of actions of current and future antibacterial substances [modified after [50].”
Comparison of Biophysical and Biologic Properties of α‐Helical Enantiomeric Antimicrobial Peptides
Chen, Y., Vasil, A. I., Rehaume, L. M., Mant, C. T., Burns, J. L., Vasil, M. L., Hancock, R. E. W., & Hodges, R. S. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00349.x · Cited by 124
“The widespread use of traditional antibiotics has resulted in the emergence of many antibiotic-resistant strains, prompting an urgent need for a new class of antibiotics (1,2).”
BackgroundEspeso, J., Isaza, A., Lee, J. Y., Sörensen, P. M., Jurado, P., Avena‐Bustillos, R. J., Olaizola, M., & Arboleya, J. C. (2021) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2021.660582 · Cited by 123
“Olive leaves may also be useful in cases where prolonged use of antibiotics encourages development of bacteria genera which pose a major resistance problem such as Klebsiella and Pseudomonas (Neu, 1992). f. Hypoglycemic Effect Oleanolic acid, a triterpenoid obtained from olive leaves, is a specific and potent TGR5 ago…”
BackgroundInfluentialFrom peptidoglycan to glycoproteins: Common features of lipid-linked oligosaccharide biosynthesis
Bugg, T. D. H., & Brandish, P. E. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb06898.x · Cited by 122
Dobson, A. P. (1995) · Trends in Ecology & Evolution · doi:10.1016/s0169-5347(00)89151-x · Cited by 122
Application of the ATC/DDD methodology to monitor antibiotic drug use
Natsch, S., Hekster, Y. A., Jong, R., Heerdink, E. R., Herings, R. M. C., & van der Meer, J. W. M. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01584358 · Cited by 122
“The monitoring of patterns of antibiotic use is very important because of the development of resistance worldwide (1-4) and because of the growing costs of these expensive groups of drugs (5-7).”
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents
Liu, H., Long, S., Rakesh, K. P., & Zha, G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111804 · Cited by 121
GARG, P., Chakraborty, S., Basu, I., Datta, S., Rajendran, K., BHATTACHARYA, T., Yamasaki, S., Bhattacharya, S., TAKEDA, Y., Nair, G. B., et al. (2000) · Epidemiology and Infection · doi:10.1017/s0950268899003957 · Cited by 121
“The definition of emerging infectious diseases in the Institution of Medicine report includes drug-resistance infections, which have been on the upsurge for the past several years [1–3].”
BackgroundStructure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase
Powers, R. A., Morandi, F., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00799-2 · Cited by 121
Immune Mechanisms of Protection
Chan, J., & Kaufmann, S. H. E. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch24 · Cited by 122
Schlüsener, M. P., Bester, K., & Spiteller, M. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-1838-9 · Cited by 120
Selection of a potential probiotic Lactobacillus strain and subsequent in vivo studies
Chang, Y.-H., Kim, J.-K., Kim, H.-J., Kim, W.-Y., Kim, Y.-B., & Park, Y.-H. (2001) · Antonie van Leeuwenhoek · doi:10.1023/a:1012213728917 · Cited by 119
“The differences in the degree of inhibition with various antibiotics were possibly due to their different actions on the cell components such as the cell wall, protein and DNA synthesis, DNA gyrase and RNA polymerase ( Neu, 1992 ).”
BackgroundBacterial diaminopimelate metabolism as a target for antibiotic design
Cox, R. J., Sutherland, A. J., & Vederas, J. C. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00044-4 · Cited by 120
Structural and kinetic characterization of a β-lactamase-inhibitor protein
Strynadka, N. C. J., Jensen, S. E., Johns, K. L., Blanchard, H., Page, M. G. P., Matagne, A., Frère, J., & James, M. N. G. (1994) · Nature · doi:10.1038/368657a0 · Cited by 120
Schwartz, R. H., Freij, B. J., Ziai, M., & Sheridan, M. J. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199702000-00004 · Cited by 120
Target-Related Applications of First Principles Quantum Chemical Methods in Drug Design
Cavalli, A., Carloni, P., & Recanatini, M. (2006) · Chemical Reviews · doi:10.1021/cr050579p · Cited by 121
Cesare, A. D., Eckert, E. M., Teruggi, A., Fontaneto, D., Bertoni, R., Callieri, C., & Corno, G. (2015) · Molecular Ecology · doi:10.1111/mec.13293 · Cited by 119
“As the emergence of antibiotic-resistant bacteria (ARB) is known to reduce the effectiveness of therapies with antibiotics (Neu 1992), it is of primary importance to identify hotspots and reservoirs of resistances, to correctly approach the problem.”
BackgroundZhang, S., Yang, G., Hou, S., Zhang, T., Li, Z., & Liang, F. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.11.031 · Cited by 118
“The increase in antibiotic resistance has caused great concern due to the reliance of antibiotics for medical, veterinary, and agricultural purposes (Neu, 1992; English and Gaur, 2010).”
BackgroundSubmicrometer-Sized Roughness Suppresses Bacteria Adhesion
Encinas, N., Yang, C.-Y. H., Geyer, F., Kaltbeitzel, A., Baumli, P., Reinholz, J., Mailänder, V., Butt, H., & Vollmer, D. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22621 · Cited by 118
Clasky, A. J., Watchorn, J., Chen, P., & Gu, F. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.030 · Cited by 118
Cole, N., Hume, E. B. H., Vijay, A. K., Sankaridurg, P. R., Kumar, N., & Willcox, M. D. P. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4068 · Cited by 118
Reasons for the Emergence of Antibiotic Resistance
Tenover, F. C., & McGowan, J. E. (1996) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199601000-00003 · Cited by 118
Sharma, A., Singh, A., Dar, M. A., Kaur, R. J., Charan, J., Iskandar, K., Haque, M., Murti, K., Ravichandiran, V., & Dhingra, S. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.008 · Cited by 120
Changing bacterial ecology during a five year period of selective intestinal decontamination
Lingnau, W., Berger, J., Javorsky, F., Fille, M., Allerberger, F. J., & Benzer, H. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90258-4 · Cited by 117
Jr, O. M., Thornsberry, C., Cardin, C. W., Smiles, K. A., & Leyden, J. J. (2002) · Acta Dermato-Venereologica · doi:10.1080/000155502320323216 · Cited by 115
“The following all products had been correctly distributed and labeled seven-point asymmetrical scale was used: total clearing (1), according to the randomized and blinded treatment code.”
BackgroundMethodOvercoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors
Zárate, S. G., Claure, M. D. L. C., Benito-Arenas, R., Revuelta, J., Santana, A. G., & Bastida, Á. (2018) · Molecules · doi:10.3390/molecules23020284 · Cited by 116
Antibacterial Carbon Dots‐Based Composites
Huang, S., Song, Y., Zhang, J., Chen, X., & Zhu, J. (2023) · Small · doi:10.1002/smll.202207385 · Cited by 116
Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria
Richter, S. G., Elli, D., Kim, H. K., Hendrickx, A. P. A., Sorg, J. A., Schneewind, O., & Missiakas, D. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217337110 · Cited by 113
“faecalis, Staphylococcus epidermidis, and Streptococcus pneumoniae (2, 39).”
BackgroundInfectious diseases: an ecological perspective
Wilson, M. E. (1995) · BMJ · doi:10.1136/bmj.311.7021.1681 · Cited by 116
“Increasingly humans have changed the earth in ways that make it easier for microbes to move and to reach vulnerable populations. Widespread use of antimicrobial agents and chemicals produces selective pressure for the survival and persistence of more resistant populations of microbes, and also of more resilient insect…”
BackgroundJakubec, P., Urbanová, V., Medříková, Z., & Zbořil, R. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602434 · Cited by 115
Banerjee, S., Vishakha, K., Das, S., Dutta, M., Mukherjee, D., Mondal, J., Mondal, S., & Ganguli, A. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110921 · Cited by 115
Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms
Li, X.-Z. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.002 · Cited by 115
Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China
Dong, L., Yan, H., & Wang, D. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn153 · Cited by 115
Zhang, H., Du, M., Jiang, H., Zhang, D., Lin, L., Ye, H., & Zhang, X. (2014) · Environmental Science Processes & Impacts · doi:10.1039/c4em00457d · Cited by 115
Mahapatra, S. S., & Karak, N. (2008) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2008.07.047 · Cited by 114
Lewis, G. (2008) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31220 · Cited by 115
“In both variants, antibiotics with different mechanisms of action are used; for example, gentamicin, tobramycin, and clindamycin inhibit protein synthesis (30S, 30S, and 50S inhibitors, respectively), vancomycin inhibits bacterial cell wall synthesis, and daptomycin inhibits protein, DNA, and RNA synthesis.(27,28) Alt…”
Nanotechnology in the Detection and Control of Microorganisms
Luo, P. G., & Stutzenberger, F. J. (2008) · Advances in applied microbiology · doi:10.1016/s0065-2164(07)00004-4 · Cited by 114
Šoltýs, J., & Quinn, M. T. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.244-252.1999 · Cited by 114
“First, increased bacterial virulence and drug resistance have complicated treatment and led to problems in tracking disease-causing pathogens (50, 69).”
Temporal dynamics of antibiotics in wastewater treatment plant influent
Coutu, S., Wyrsch, V., Wynn, H. K., Rossi, L., & Barry, D. A. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.04.017 · Cited by 116
Ca2+ and Mg2+ bind tetracycline with distinct stoichiometries and linked deprotonation
Jin, L., Amaya-Mazo, X., Apel, M. E., Sankisa, S., Johnson, E. A., Zbyszynska, M. A., & Han, A. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.04.005 · Cited by 114
Siderophores of the Pseudomonadaceae sensu stricto(Fluorescent and Non-Fluorescent Pseudomonas spp.)
Budzikiewicz, H. (2004) · Springer eBooks · doi:10.1007/978-3-7091-0581-8_2 · Cited by 122
The Natural Evolutionary Relationships among Prokaryotes
Gupta, R. S. (2000) · Critical Reviews in Microbiology · doi:10.1080/10408410091154219 · Cited by 115
Chou, S., Shao, C., Wang, J., Shan, A., Xu, L., Dong, N., & Li, Z. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.002 · Cited by 112
Kumar, S. H., Lekshmi, M., Parvathi, A., Ojha, M., Wenzel, N., & Varela, M. F. (2020) · Microorganisms · doi:10.3390/microorganisms8020266 · Cited by 114
Appropriate antibiotic use and why it is important: the challenges of bacterial resistance
Lieberman, J. M. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000101851.57263.63 · Cited by 114
Structural Milestones in the Reaction Pathway of an Amide Hydrolase
Beadle, B. M., Trehan, I., Focia, P. J., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00725-6 · Cited by 112
Improved Derivatives of Bactenecin, a Cyclic Dodecameric Antimicrobial Cationic Peptide
Wu, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1274 · Cited by 112
“The rapid emergence of antibiotic resistance has been of great concern in recent years (7).”
BackgroundGrowth and Laboratory Maintenance of Staphylococcus aureus
Missiakas, D. M., & Schneewind, O. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc09c01s28 · Cited by 123
“STRATEGIC PLANNING Strain Selection Owing to its niche as a commensal, S. aureus is readily exposed to all antibiotic therapies (Neu, 1992), which has led to the selection of drug-resistant strains commonly designated as MRSA for methicillin-resistant S. aureus (see also UNIT 9C.2).”
Background1.85 Å Resolution Structure of the ZincII β-Lactamase from Bacillus cereus
Carfı́, A., Duée, E. D., Galleni, M., Frère, J., & Dideberg, O. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444997010627 · Cited by 110
Metadata
- Authors
- Neu, H. C.
- Affiliations
- Columbia University (US)
- Corresponding author
- Neu, Harold C.
- Venue
- Science
- Published
- 1992-08-21
- Volume
- 257
- Issue
- 5073
- Pages
- 1064-1073
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1980595924
- Cited by
- 2,834
- References
- 109
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
- FWCI
- 46.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review